20/20 BIOLABS, INC.: operating_income
| Value | {"amount": -772180, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-03-31 |
| Status | current |
| Entity | 20/20 BIOLABS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:27:01.038089+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e7e6ca3f-3e8a-476d-9273-7f17d27a6477
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-059542 · Open the official SEC filing →Retrieved: 2026-08-19T11:27:01.038089+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001139685/operating-income/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e7e6ca3f-3e8a-476d-9273-7f17d27a6477
History
- no predecessors — first report